Press Releases Prelude Therapeutics Incorporated

Equities

PRLD

US74065P1012

Market Closed - Nasdaq Other stock markets 01:30:00 09/05/2024 am IST			5-day change	1st Jan Change
3.59 ^USD	-2.97%		-4.77%	-15.93%

07/05	Prelude Therapeutics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
10/04	Bryant D. Lim to Serve as Principal Financial Officer and Principal Accounting Officer of Prelude Therapeutics Incorporated	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update	07/05	GL
Prelude Highlights Continued Strength of Discovery Engine at 2024 AACR Annual Meeting	10/04	GL
Prelude Announces Acceptance of Multiple Preclinical Abstracts at the 2024 AACR Annual Meeting	06/03	GL
Prelude Therapeutics to Participate in Barclays Global Healthcare Conference	01/03	GL
Prelude Therapeutics Reports Full Year 2023 Financial Results and Outlines Key Objectives for 2024	16/02	GL
Prelude Therapeutics Announces $25 Million Private Placement	11/12	GL
Prelude Therapeutics Incorporated : Announces $25 Million Private Placement - Form 8-K	11/12	PU
Prelude Announces Strategic Pipeline Progress and Updates, including its Partnership with AbCellera, and Reports Third Quarter Financial Results	02/11	GL
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology	02/11	GL
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology	02/11	AQ
Prelude Announces Multiple Clinical and Preclinical Poster Presentations at AACR-NCI-EORTC International Conference	14/23/14	AQ
Prelude Announces Multiple Clinical and Preclinical Poster Presentations at AACR-NCI-EORTC International Conference	14/23/14	GL
Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in September	29/23/29	GL
Prelude Therapeutics Incorporated : August 2023 Corporate Deck	14/23/14	PU
Prelude Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update	03/23/03	AQ
Prelude Therapeutics To Participate in Jefferies Healthcare Conference	31/23/31	AQ
PRELUDE THERAPEUTICS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	20/23/20	AQ
Prelude Therapeutics Announces Pricing of Public Offering	18/23/18	AQ
Prelude Therapeutics Announces Launch of Proposed Public Offering	18/23/18	AQ
Prelude Therapeutics Incorporated : May 2023 Corporate Deck	08/23/08	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Prelude Therapeutics Incorporated

Equities

PRLD

US74065P1012

Press Releases

Filters